1803 PEGGY: A phase II randomised study of the PI3-kinase (PI3K) inhibitor pictilisib (GDC-0941) plus paclitaxel in patients (pts) with hormone receptor (HR)-positive, HER2-negative locally recurrent or metastatic breast cancer (mBC). (September 2015)

Record Type:
Journal Article
Title:
1803 PEGGY: A phase II randomised study of the PI3-kinase (PI3K) inhibitor pictilisib (GDC-0941) plus paclitaxel in patients (pts) with hormone receptor (HR)-positive, HER2-negative locally recurrent or metastatic breast cancer (mBC). (September 2015)
Main Title:
1803 PEGGY: A phase II randomised study of the PI3-kinase (PI3K) inhibitor pictilisib (GDC-0941) plus paclitaxel in patients (pts) with hormone receptor (HR)-positive, HER2-negative locally recurrent or metastatic breast cancer (mBC)
Authors:
Vuylsteke, P.
Huizing, M.
Petrakova, K.
Roylance, R.
Laing, R.
Chan, S.
Abell, F.
Apt, D.
Zhou, J.
Singel, S.
Fehrenbacher, L.
Abstract:
Is Part Of:
European journal of cancer. Volume 51:(2015)Supplement 3
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Issue Display:
Volume 51, Issue 3 (2015)
Year:
2015
Volume:
51
Issue:
3
Issue Sort Value:
2015-0051-0003-0000
Page Start:
S265
Page End:
S266
Publication Date:
2015-09
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0959-8049(16)30757-2 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
2029.xml